» Articles » PMID: 25744304

Contraceptive Use Before and After Gastric Bypass: a Questionnaire Study

Overview
Journal Obes Surg
Date 2015 Mar 7
PMID 25744304
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: At present, women are recommended to avoid pregnancy 12-18 months after bariatric surgery. Our aim in this study was to describe patterns of contraceptive use before and after gastric bypass in Sweden, and to describe the contraceptive counseling given preoperatively to women undergoing gastric bypass.

Methods: In October 2012, a questionnaire was sent to 1000 Swedish women who all had undergone gastric bypass during 2010. The women had been included in the Scandinavian Obesity Surgery Register at time of surgery. The main outcome measures were patterns of use of contraception before and after bariatric surgery.

Results: The response rate was 57 %. The most commonly used contraceptive methods were intrauterine devices, 29 % preoperatively and 26 % postoperatively even though there was a postoperative switch from the copper intrauterine device to the levonorgestrel intrauterine system. Thirty percent did not use any contraceptive during the first 12 months after surgery. Sixty percent of the responders were aware of the recommendations to avoid pregnancy after surgery.

Conclusions: Many women who undergo bariatric surgery are not using any contraceptive method despite the recommendation that they should avoid pregnancy for at least 12 months. There is a great need to improve contraceptive counseling for this growing group of women.

Citing Articles

A Scoping Review: Bariatric Providers' Knowledge and Behaviors Related to Contraceptive Counseling.

Shaikh S, Cruz K, Oladipo A, Figueroa M Obes Surg. 2024; 34(4):1358-1365.

PMID: 38376636 DOI: 10.1007/s11695-024-07090-y.


Medical and Psychological Aspects of Pregnancy in Women with Obesity and after Bariatric Surgery.

Bak-Sosnowska M, Naworska B Nutrients. 2023; 15(19).

PMID: 37836575 PMC: 10574796. DOI: 10.3390/nu15194289.


Women in larger bodies' experiences with contraception: a scoping review.

Boyce T, Neiterman E Reprod Health. 2021; 18(1):89.

PMID: 33926501 PMC: 8082612. DOI: 10.1186/s12978-021-01139-2.


The Impact of Bariatric Surgery on Menstrual Abnormalities-a Cross-Sectional Study.

Rozanska-Waledziak A, Bartnik P, Kacperczyk-Bartnik J, Czajkowski K, Waledziak M Obes Surg. 2020; 30(11):4505-4509.

PMID: 32661954 PMC: 7524851. DOI: 10.1007/s11695-020-04840-6.


Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.

Ginstman C, Kopp Kallner H, Fagerberg-Silwer J, Carlsson B, Arlemalm A, Bottiger Y Obes Surg. 2020; 30(6):2217-2224.

PMID: 32030619 PMC: 7475059. DOI: 10.1007/s11695-020-04447-x.


References
1.
Abdollahi M, Cushman M, Rosendaal F . Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89(3):493-8. View

2.
Gerrits E, Ceulemans R, Van Hee R, Hendrickx L, Totte E . Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg. 2003; 13(3):378-82. DOI: 10.1381/096089203765887697. View

3.
Victor A, Odlind V, Kral J . Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass. Gastroenterol Clin North Am. 1987; 16(3):483-91. View

4.
Granstrom L, Backman L . Fetal growth retardation after gastric banding. Acta Obstet Gynecol Scand. 1990; 69(6):533-6. DOI: 10.3109/00016349009013332. View

5.
Goldhaber S, Grodstein F, Stampfer M, Manson J, Colditz G, Speizer F . A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997; 277(8):642-5. View